Cytokinetics Inc. buy Royal Bank of Canada
Start price
11.11.25
/
50%
€55.50
Target price
11.11.26
€75.30
Performance (%)
-3.60%
Price
23.12.25
€53.50
Summary
This prediction is currently active. With a performance of -3.60%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 11.11.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 4.902% | 4.902% |
| iShares Core DAX® | 1.732% | 4.638% |
| iShares Nasdaq 100 | 3.304% | 0.517% |
| iShares Nikkei 225® | 2.342% | 0.972% |
| iShares S&P 500 | 2.357% | 0.872% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Royal Bank Of Canada from $82.00 to $87.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.40
07.05.25
07.05.25
€70.52
07.05.26
07.05.26
81.97%
23.12.25
23.12.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.80
18.12.24
18.12.24
€78.17
18.12.25
18.12.25
14.63%
19.12.25
19.12.25